10 SEP 2025 · SCIENTIFIC PRESENTATION
Circular mRNA in vivo CAR-T presented at RNA World 2025
Byterna presented preclinical work on circular mRNA-based CAR-T pharmacology and its potential for in vivo immune-cell programming.
The presentation described preclinical circular mRNA CAR-T research and the intended role of CellectLNP delivery in future in vivo immune-cell programming.
The update does not report human clinical results and should not be read as evidence from BR101 participants.